BioVie, Inc. (BIVI) financial statements (2020 and earlier)

Company profile

Business Address 2120 COLORADO AVE.
LOS ANGELES, CA 90404
State of Incorp. NV
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments32493409721,6302,13646
Cash and cash equivalents32493409721,6302,13646
Other current assets551516334    
Total current assets:5547656749721,6302,13646
Noncurrent Assets
Intangible assets, net (including goodwill)1,7861,8431,9001,6122,0152,0722,130
Goodwill346346346 346346346
Intangible assets, net (excluding goodwill)1,4401,4971,5551,6121,6691,7271,784
Total noncurrent assets:1,7861,8431,9001,6122,0152,0722,130
TOTAL ASSETS:2,3402,6082,5742,5843,6454,2082,175
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,085684443 1051831,238
Accounts payable1,085684443 105183884
Employee-related liabilities      354
Due to related parties30      
Other undisclosed current liabilities3,26910,645     
Total current liabilities:4,38411,329443 1051831,238
Noncurrent Liabilities
Liabilities, other than long-term debt      576
Due to related parties      576
Other undisclosed noncurrent liabilities      250
Total noncurrent liabilities:      826
Total liabilities:4,38411,329443 1051832,064
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,044)(8,721)2,131 3,5414,025111
Common stock16551 323210
Additional paid in capital19,47219,3979,342 9,2679,2514,870
Accumulated deficit(21,517)(28,182)(7,262) (5,758)(5,258)(4,769)
Other undisclosed stockholders' equity attributable to parent     0 
Other undisclosed stockholders' equity   2,785  (0)
Total stockholders' equity:(2,044)(8,721)2,1312,7853,5414,025111
Other undisclosed liabilities and equity      0
TOTAL LIABILITIES AND EQUITY:2,3402,6082,5742,7853,6454,2082,175

Income statement (P&L) ($ in thousands)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Gain on disposition of assets for financial service operations7,396363     
Net investment income     51 
Gross profit:7,396363   51 
Operating expenses(710)(706)(656)(848)(501)(491)(524)
Other undisclosed operating loss(7,396)(363)   (51) 
Operating loss:(710)(706)(656)(848)(501)(491)(524)
Interest and debt expense(21)(3,478)(0)  (0)(31)
Loss before gain (loss) on sale of properties:(731)(4,184)(656)(848)(501)(492)(555)
Other undisclosed net income7,3963630009320
Net income (loss):6,665(3,821)(656)(848)(501)440(555)
Other undisclosed net loss attributable to parent      (21)
Net income (loss) available to common stockholders, diluted:6,665(3,821)(656)(848)(501)440(576)

Comprehensive Income ($ in thousands)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Net income (loss):6,665(3,821)(656)(848)(501)440(555)
Comprehensive income (loss), net of tax, attributable to parent:6,665(3,821)(656)(848)(501)440(555)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: